Updated risk assessment concerning the risk to wild mammals for the active substance gamma‐cyhalothrin

Abstract The risk assessment for gamma‐cyhalothrin in light of confirmatory data requested following approval in accordance with Article 6(1) of Directive 91/414/EEC and Article 6(f) of Regulation (EC) No 1107/2009 concluded that the long‐term risk to wild mammals from the proposed representative uses of gamma‐cyhalothrin was not fully addressed. Following further considerations during the decision‐making process, the European Commission asked EFSA to update the risk assessment for wild mammals and consider a restriction to the proposed good agricultural practice (GAP). The outcome of the updated peer review of the risk assessment for wild mammals is presented.